What is the meningitis vaccine?

Meningitis vaccine is vaccination that reduces the chances of contractual bacterial meningitis. Meningitis is an infection that affects fluid and membranes around the brain and spinal cord. It is often viral, but it can also be bacterial. The meningitis vaccine protects only from bacterial strains. The vaccine is particularly recommended for ages 11 to 18 years and behind them for students living in college dormitories, because meningitis is easier to spread in tight neighborhoods. There are two types of vaccines that prevent meningitis: Menomune and Menaktra. Like influenza vaccines, vaccines against meningitis cannot protect against all bacterial trunks, but protect against the most common tribes.

Bacterial meningitis is a serious disease known to kill otherwise healthy individuals. It can be closed in itself or as a result of another disease, such as strip of the neck or pneumonia. Those who survive the disease often have permanent effects such as mental and physical disability. DespiteThe way meningitis seriously reacts with some, others are able to fully recover. The initial symptoms include stiff neck, fever and headache. As this proceeds, symptoms of vomiting, nausea, drowsiness and sensitivity to light may also be manifested. If symptoms occur, it is important to seek hospital treatment immediately. Viral meningitis is much milder than its bacterial cousin and is usually solved without the need for serious treatment.

The first vaccine against meningitis became common in 1981 with meningococcal vaccine polysaccharides, otherwise known as Menomune or M.P.S.V.4. Menomune significantly reduced cases of bacterial meningitis around the world. This was particularly affected by the spread of HIB, which was suddenly the main cause of bacterial meningitis in young age groups. Today, HIB vaccination for All children aged five years are recommended. In 2005 it was introduced by second vaccineOn against meningitis, called Menacre or M.C.V.4. Menacero is approved for 11 to 55 years. Today, most people who receive a vaccine against meningitis are likely to get Menomune and Menaktra. Menomune is preferred for ages of 2-10 and 55 and older, while Menacre is used for ages between these ranges.

Meningitis occurs in small outbreaks, such as a sports team, school class or dormitory floor. If the focus occurs, people can prevent their likelihoods of infection of bacteria by not share food or drinks with others and often wash their hands. Bacterial meningitis spreads through the respiratory system, so sharing any saliva or standing around individuals with cough or sneezing can significantly increase the likelihood of disease.